Re appointment of Mr. Murali Meraga (DIN:05237507) as an Managing Director of the company
Vista Pharmaceuticals Ltd. Press Release Aug 13 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The Company
- Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole Time Director Of The Company
- Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended 30.06.2025
- Results - Unaudited Financial Results For The Quarter Ended 30.06.2025
- Vista Pharmaceuticals Ltd. Press Release Aug 06 2025
Later from Vista Pharmaceuticals
- 34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025
- Reg. 34 (1) Annual Report.
- Intimation Of Book Closure Regarding 34" Annual General Meeting
- Vista Pharmaceuticals Ltd. Press Release Sep 08 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals